BioMarin Pharmaceutical Inc. (BMRN)
NASDAQ
Closed
Oct 6, 2026
Day's Range
55.7652 wk Range
49.26Overview - BMRN - BioMarin Pharmaceutical Inc.
Key Statistics
Valuation
Enterprise Value
14.39B
P/E (Trailing)
‪154.54‬
P/E (Forward)
‪8.63‬
PEG Ratio
‪-1.89‬
Price / Sales (TTM)
‪3.24‬
Price / Book
‪1.75‬
EV / EBITDA
‪22.30‬
Profitability
Gross Margin
‪79.50%‬
Profit Margin
‪2.14%‬
Operating Margin
‪21.16%‬
Return on Assets
‪3.25%‬
Return on Equity
‪1.18%‬
Ownership
Shares Outstanding
193.53M
Float
192.63M
Short % of Shares Outstanding
‪5.21%‬
Held by Insiders
‪0.34%‬
Held by Institutions
‪103.51%‬
Price stats
Beta
‪0.23‬
50-Day Avg
‪63.98‬
200-Day Avg
‪58.67‬
Dividends
Payout Ratio
‪0.00%‬
Analyst Consensus
27 analysts
Average price target
‪$ 91.04‬Shariah Compliance
Report Date: Feb 15, 2025
Screened by Zoya using the AAOIFI methodology.
Market Cap - BMRN - BioMarin Pharmaceutical Inc.
Peers - BMRN - BioMarin Pharmaceutical Inc.
Peer Comparison
Compared with companies in Biotechnology listed on NASDAQ.
- BMRNNASDAQBioMarin Pharmaceutical Inc.11.06BMarket Cap+2.75%52-week change154.54P/E (Trailing)‪2.14%‬Profit Margin
- ARGXNASDAQArgenx SE57.50BMarket Cap+14.28%52-week change34.96P/E (Trailing)‪32.26%‬Profit Margin
- ALNYNASDAQAlnylam Pharmaceuticals, Inc.29.40BMarket Cap-105.72%52-week change38.35P/E (Trailing)‪16.12%‬Profit Margin
- BNTXNASDAQBioNTech SE American Depositary Share24.34BMarket Cap-8.52%52-week change160.80P/E (Trailing)‪-63.63%‬Profit Margin
- ASNDNASDAQAscendis Pharma A/S14.99BMarket Cap+7.48%52-week change17.72P/E (Trailing)‪70.84%‬Profit Margin
- BBIONASDAQBridgeBio Pharma Inc.13.14BMarket Cap+18.80%52-week change-17.80P/E (Trailing)‪-97.02%‬Profit Margin
- AXSMNASDAQAxsome Therapeutics Inc.9.37BMarket Cap+33.09%52-week change-48.69P/E (Trailing)‪-24.67%‬Profit Margin
Profile Summary - BMRN - BioMarin Pharmaceutical Inc.
About
BioMarin Pharmaceutical Inc. is a global biotechnology company focused on developing and commercializing therapies for rare genetic and metabolic diseases. Its portfolio includes approved medicines and advanced treatments such as enzyme replacement therapies, gene therapies, and other specialized biologics designed…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Shariah compliance data provided by Zoya. Charting by TradingView.
Last updated:
